Phospho-mTOR expression in human glioblastoma microglia-macrophage cells

Lucia Lisi, Pierluigi Navarra, Marta Chiavari, Marco Pizzoferrato, Annunziato Mangiola, Sergey Kalinin, Douglas L. Feinstein

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

6 Citazioni (Scopus)


The glioblastoma (GBM) immune microenvironment is highly heterogeneous, and microglia may represent 30–70% of the entire tumor. However, the role of microglia and other specific immune populations is poorly characterized. Activation of mTOR signaling occurs in numerous human cancers and has roles in microglia-glioma cell interactions. We now show in human tumor specimens (42 patients), that 39% of tumor-associated microglial (TAM) cells express mTOR phosphorylated at Ser-2448; and similar mTOR activation is observed using a human microglia-glioma interaction paradigm. In addition, we confirm previous studies that microglia express urea and ARG1 (taken as M2 marker) in the presence of glioma cells, and this phenotype is down-regulated in the presence of a mTOR inhibitor. These results suggest that mTOR suppression in GBM patients might induce a reduction of the M2 phenotype expression in up to 40% of all TAMs. Since the M2 profile of microglial activation is believed to be associated with tumor progression, reductions in that phenotype may represent an additional anti-tumor mechanism of action of mTOR inhibitors, along with direct anti-proliferative activities.
Lingua originaleEnglish
pagine (da-a)104485-147797
Numero di pagine43313
RivistaNeurochemistry International
Stato di pubblicazionePubblicato - 2019


  • Glioblastoma
  • Microglia
  • Molecularly targeted therapies
  • TSC2
  • Tumor microenvironment
  • mTOR


Entra nei temi di ricerca di 'Phospho-mTOR expression in human glioblastoma microglia-macrophage cells'. Insieme formano una fingerprint unica.

Cita questo